Showing 2,241 - 2,260 results of 11,505 for search '"The Progressives"', query time: 0.11s Refine Results
  1. 2241

    Ultrasound B-Scan for Posterior Segment and Extraocular Evaluation in Ocular Cysticercosis by Bhatt VD, Bhatt KD, Bhatt DC, Dabir S, Sheth JU, Berendschot TTJM, Erckens RJ, Webers CAB

    Published 2025-01-01
    “…Intra-vitreous cysticercosis (n=9) exhibited thin-walled cysts with minimal inflammation, progressing to thickened cyst walls in the late stages. …”
    Get full text
    Article
  2. 2242

    Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation by Shaochun Zhang, Zhijie Xing, Jing Ke

    Published 2025-02-01
    “…Additionally, AKT inhibits immune cell infiltration in osteosarcoma and suppresses immune responses during osteosarcoma progression. β-elemene may influence osteosarcoma progression by mediating TP53 to regulate PTEN and subsequently AKT1. …”
    Get full text
    Article
  3. 2243

    Cytokines in Liver Cirrhosis (Their Importance in Assessing Activity and Decompensation) by G. K. Mirodzhov, S. D. Pulatova

    Published 2023-11-01
    “…High levels of proinflammatory cytokines in blood serum in liver cirrhosis correlate with the activity and degree of decompensation, which indicates their important role in the pathogenesis and progression of the pathological process.…”
    Get full text
    Article
  4. 2244

    The value of FDG-PET/CT metabolic parameters and treatment metabolic response in predicting long-term survival of patients with diffuse large B-cell lymphoma by Abbas Yousefikoma, Mohamad Mehdi Karimy Taha

    Published 2025-01-01
    “…All subjects were followed up for 2 years to assess progression-free survival (PFS) and overall survival (OS). …”
    Get full text
    Article
  5. 2245

    Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece by George Gourzoulidis, Oresteia Zisimopoulou, Nadia Boubouchairopoulou, Christina Michailidi, Chrissy Lowry, Charalampos Tzanetakos, Georgia Kourlaba

    Published 2022-02-01
    “…**Methods:** A partitioned survival model with three health states, referring to pre-progression, progressed disease, and death, was locally adapted from a Greek payer perspective over a lifetime horizon. …”
    Get full text
    Article
  6. 2246
  7. 2247

    CircWDR78 inhibits the development of colorectal cancer by regulating the miR-653-3p/RGS4 axis by Chu Hao, Yunju Pu, Jiunian Li, Zhi Zhong, Zhaohui Huang, Xue Wang

    Published 2025-02-01
    “…Conclusion This discovery highlights the significance of circWDR78 as a potential regulatory axis of miR-653-3p/RGS4 in CRC progression.…”
    Get full text
    Article
  8. 2248

    Fatal Disseminated Kaposi's Sarcoma due to Immune Reconstitution Inflammatory Syndrome following HAART Initiation by Fatuma Catherine Atieno Odongo

    Published 2013-01-01
    “…The patient rapidly progressed to death in 5 days after worsening pulmonary infiltrates and multiple organ failure.…”
    Get full text
    Article
  9. 2249

    FEATURES OF DEVELOPMENT OF INTERNATIONAL LEASING IN ECONOMY OF FOREIGN COUNTRIES by V. Vesina

    Published 2016-05-01
    “…The role of renting and scientific and technical progress in mechanism forming of international leasing is shown. …”
    Get full text
    Article
  10. 2250

    Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters by Katherine J. P. Schwenger, Julia K. Copeland, Yasaman Ghorbani, Lina Chen, Elena M. Comelli, David S. Guttman, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard

    Published 2025-01-01
    “…Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a range of histological findings from the generally benign simple steatosis to steatohepatitis (MASH) which can progress to fibrosis and cirrhosis. Several factors, including the microbiome, may contribute to disease progression. …”
    Get full text
    Article
  11. 2251

    Deep Brain Stimulation in Parkinson’s Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms by Dustin Anderson, Grayson Beecher, Fang Ba

    Published 2017-01-01
    “…Parkinson’s disease (PD) is a progressive neurodegenerative condition characterized by bradykinesia, tremor, rigidity, and postural instability (PI), in addition to numerous nonmotor manifestations. …”
    Get full text
    Article
  12. 2252

    Case report: Periorbital pilomatricoma: a rare benign skin tumor misdiagnosed as cellulitis by Rahul Kumar, Jane Z. Spadaro, Jane Z. Spadaro, Alon Kahana, Alon Kahana, Alon Kahana

    Published 2025-01-01
    “…PurposeWe describe an unusual case of a rapidly progressive pilomatricoma along the left brow, which was initially misdiagnosed and treated as preseptal cellulitis. …”
    Get full text
    Article
  13. 2253

    The Role of PPAR Gamma in Systemic Sclerosis by Andréa Tavares Dantas, Michelly Cristiny Pereira, Moacyr Jesus Barreto de Melo Rego, Laurindo Ferreira da Rocha, Ivan da Rocha Pitta, Cláudia Diniz Lopes Marques, Angela Luzia Branco Pinto Duarte, Maira Galdino da Rocha Pitta

    Published 2015-01-01
    “…SSc has a poor prognosis because no therapy has been shown to reverse or arrest the progression of fibrosis, representing a major unmet medical need. …”
    Get full text
    Article
  14. 2254

    In-situ profiling of glycosylation on single cells with surface plasmon resonance imaging by Xiaoyin Liu, Jinbiao Ma, Yunrui Zhang, Yi Xu, Yunxiao Wang, Dehong Yang, Di Wang, Qingjun Liu, Fenni Zhang

    Published 2025-01-01
    “…Abstract Cellular glycosylation is crucial for cell recognition, signal transduction, and the development of various diseases, especially in tumor initiation, progression, and metastasis. Current glycosylation profiling methods normally involve laborious sample processing and labeling and lack in-situ quantitative analysis. …”
    Get full text
    Article
  15. 2255

    Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game by Paqui G. Través, Alfonso Luque, Sonsoles Hortelano

    Published 2012-01-01
    “…The interaction between tumor progression and innate immune system has been well established in the last years. …”
    Get full text
    Article
  16. 2256

    The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy? by Sonja S. Mojsilovic, Slavko Mojsilovic, Victor H. Villar, Juan F. Santibanez

    Published 2021-01-01
    “…Besides transformed cells, the tumors are composed of various cell types that contribute to undesirable tumor progression. Tumor-associated macrophages (TAMs) are the most abundant innate immune cells in the tumor microenvironment (TME). …”
    Get full text
    Article
  17. 2257

    The development of determining motor qualities in children aged 10-12 by Dragoș Vasile SĂVESCU*, Pavel Ionuț PETRICA, Bianca Cristina SĂVESCU

    Published 2024-11-01
    “…At the end of the research, it was observed that the progress between the initial and final testing is obvious, with the majority of players making progress between the two tests.…”
    Get full text
    Article
  18. 2258

    Dari Ratu Kembang Kacang hingga Berlanggam di Istana: Kiprah Waldjinah sebagai Penyanyi Istana Negara by Rafngi Mufidah, Dhanang Respati Puguh

    Published 2023-06-01
    “…Apart from that, this study also reveals Waldjinah's progress in participating in singing competitions and led her to the State Palace. …”
    Get full text
    Article
  19. 2259

    Cellular senescence: from homeostasis to pathological implications and therapeutic strategies by Chunhong Li, Yixiao Yuan, YingDong Jia, Qiang Zhou, Qiang Wang, Xiulin Jiang

    Published 2025-02-01
    “…The interaction between cellular senescence and cancer is complex and multifaceted, senescence can both promote and inhibit tumor progression through various mechanisms. M6A methylation modification regulates the aging process of cells and tissues by modulating senescence-related genes. …”
    Get full text
    Article
  20. 2260

    Active ingredients of traditional Chinese medicine inhibit NOD-like receptor protein 3 inflammasome: a novel strategy for preventing and treating heart failure by Ruifang Lin, Ruifang Lin, Yunfeng Yu, Lixin Du, Zehui Ding, Zehui Ding, Ziyan Wang, Ziyan Wang, Jiaming Wei, Jiaming Wei, Zhihua Guo, Zhihua Guo

    Published 2025-01-01
    “…Activation of the NOD-like receptor protein 3 (NLRP3) inflammasome is regarded as a pivotal factor in the onset and progression of HF. Therefore, inhibiting the activation of the NLRP3 inflammasome may represent a promising therapeutic approach for preventing and treating HF. …”
    Get full text
    Article